187 related articles for article (PubMed ID: 19672612)
1. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
Musshoff F; Trafkowski J; Lichtermann D; Madea B
Int J Legal Med; 2010 Sep; 124(5):499-503. PubMed ID: 19672612
[TBL] [Abstract][Full Text] [Related]
2. Patterns of drug use by participants in the Western Australian methadone program, 1984-1991.
Swensen G; Ilett KF; Dusci LJ; Hackett LP; Ong RT; Quigley AJ; Lenton S; Saker R; Caporn J
Med J Aust; 1993 Sep; 159(6):373-6. PubMed ID: 8104312
[TBL] [Abstract][Full Text] [Related]
3. Cocaine and opiate concentrations in hair from subjects in a heroin maintenance program in comparison to a methadone substituted group.
Musshoff F; Lachenmeier K; Lichtermann D; Madea B
Int J Legal Med; 2009 Sep; 123(5):363-9. PubMed ID: 18661141
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment.
Shakleya DM; Dams R; Choo RE; Jones H; Huestis MA
J Anal Toxicol; 2010; 34(1):17-25. PubMed ID: 20109298
[TBL] [Abstract][Full Text] [Related]
6. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
7. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
Cone EJ
Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
[TBL] [Abstract][Full Text] [Related]
8. A review of patients on methadone maintenance.
Taj R; Keenan E; O'Connor JJ
Ir Med J; 1995; 88(6):218-9. PubMed ID: 8575924
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
10. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
Dale RC; Ford LT; Street C
Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
[TBL] [Abstract][Full Text] [Related]
11. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
12. Screening for illicit heroin use in patients in a heroin-assisted treatment program.
Rook EJ; Huitema AD; van den Brink W; Hillebrand MJ; van Ree JM; Beijnen JH
J Anal Toxicol; 2006; 30(6):390-4. PubMed ID: 16872571
[TBL] [Abstract][Full Text] [Related]
13. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
[TBL] [Abstract][Full Text] [Related]
14. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
Gastberger S; Baumgartner MR; Soyka M; Quednow BB; Hulka LM; Herdener M; Seifritz E; Mutschler J
Eur Addict Res; 2019; 25(4):207-212. PubMed ID: 31067528
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a human on-site urine multidrug test for emergency use with dogs.
Teitler JB
J Am Anim Hosp Assoc; 2009; 45(2):59-66. PubMed ID: 19258416
[TBL] [Abstract][Full Text] [Related]
17. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
[TBL] [Abstract][Full Text] [Related]
18. Sweat testing in opioid users with a sweat patch.
Kintz P; Tracqui A; Mangin P; Edel Y
J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
Petrakis I; Carroll KM; Nich C; Gordon L; Kosten T; Rounsaville B
Drug Alcohol Depend; 1998 May; 50(3):221-6. PubMed ID: 9649975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
